One of the first states in the country to study a new coronavirus vaccine will be Wisconsin.
UW Health announced today the upcoming study is of a vaccine developed by pharmaceutical company Astra-Zeneca. The study is currently recruiting 16-hundred participants for the Phase 3 randomized, double-blind clinical trial. There are 100 clinical sites around the country participating in the trial.
